Patents by Inventor Tetsuo Hayama

Tetsuo Hayama has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11957660
    Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.
    Type: Grant
    Filed: September 22, 2022
    Date of Patent: April 16, 2024
    Assignee: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Tetsuo Hayama, Tomohiro Takahashi, Tomoyuki Omura, Kouji Hayashi, Munetomo Matsuda, Tadashi Miyazawa
  • Publication number: 20240033248
    Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.
    Type: Application
    Filed: September 29, 2023
    Publication date: February 1, 2024
    Applicant: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Tetsuo HAYAMA, Tomohiro TAKAHASHI, Tomoyuki OMURA, Kouji HAYASHI, Munetomo MATSUDA, Tadashi MIYAZAWA
  • Patent number: 11826352
    Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.
    Type: Grant
    Filed: May 5, 2021
    Date of Patent: November 28, 2023
    Assignee: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Tetsuo Hayama, Tomohiro Takahashi, Tomoyuki Omura, Kouji Hayashi, Munetomo Matsuda, Tadashi Miyazawa
  • Publication number: 20230030285
    Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.
    Type: Application
    Filed: September 22, 2022
    Publication date: February 2, 2023
    Applicant: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Tetsuo HAYAMA, Tomohiro TAKAHASHI, Tomoyuki OMURA, Kouji HAYASHI, Munetomo MATSUDA, Tadashi MIYAZAWA
  • Patent number: 11478450
    Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.
    Type: Grant
    Filed: December 23, 2021
    Date of Patent: October 25, 2022
    Assignee: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Tetsuo Hayama, Tomohiro Takahashi, Tomoyuki Omura, Kouji Hayashi, Munetomo Matsuda, Tadashi Miyazawa
  • Publication number: 20220110915
    Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.
    Type: Application
    Filed: December 23, 2021
    Publication date: April 14, 2022
    Applicant: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Tetsuo HAYAMA, Tomohiro TAKAHASHI, Tomoyuki OMURA, Kouji HAYASHI, Munetomo MATSUDA, Tadashi MIYAZAWA
  • Patent number: 11241416
    Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.
    Type: Grant
    Filed: March 26, 2021
    Date of Patent: February 8, 2022
    Assignee: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Tetsuo Hayama, Tomohiro Takahashi, Tomoyuki Omura, Kouji Hayashi, Munetomo Matsuda, Tadashi Miyazawa
  • Publication number: 20210251965
    Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.
    Type: Application
    Filed: May 5, 2021
    Publication date: August 19, 2021
    Applicant: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Tetsuo HAYAMA, Tomohiro TAKAHASHI, Tomoyuki OMURA, Kouji HAYASHI, Munetomo MATSUDA, Tadashi MIYAZAWA
  • Publication number: 20210212990
    Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.
    Type: Application
    Filed: March 26, 2021
    Publication date: July 15, 2021
    Applicant: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Tetsuo HAYAMA, Tomohiro TAKAHASHI, Tomoyuki OMURA, Kouji HAYASHI, Munetomo MATSUDA, Tadashi MIYAZAWA
  • Patent number: 10987341
    Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.
    Type: Grant
    Filed: May 12, 2020
    Date of Patent: April 27, 2021
    Assignee: MITSUBISHI TANABE PHARMA CORPORATION
    Inventors: Tetsuo Hayama, Tomohiro Takahashi, Tomoyuki Omura, Kouji Hayashi, Munetomo Matsuda, Tadashi Miyazawa
  • Publication number: 20200268712
    Abstract: An edaravone suspension for human oral administration includes edaravone particles, a dispersant, and water.
    Type: Application
    Filed: May 12, 2020
    Publication date: August 27, 2020
    Applicant: Mitsubishi Tanabe Pharma Corporation
    Inventors: Tetsuo Hayama, Tomohiro Takahashi, Tomoyuki Omura, Kouji Hayashi, Munetomo Matsuda, Tadashi Miyazawa
  • Patent number: 5575575
    Abstract: A small-sized printer includes a printing section equipped with a shuttle head in which impact-type printing units are arranged in juxtaposition in a sub-scanning direction, a cylindrical cam for reciprocating the shuttle head in the sub-scanning direction, and paper feeding rollers for feeding a standard sheet in a main scanning direction; an input device for inputting information; a display device for displaying information; a RAM for storing information; and a CPU for controlling the printing section, the input section, the display device and the RAM and performing calculation on information. The printing section and the paper feeding rollers are provided in a body case in such a way as to be exposed where they are opposed to a case cover, which has a flat platen and spring members at positions opposed to the printing section, and ribs adapted to come into contact with the standard sheet and serving as a positioning device and as a sliding guide.
    Type: Grant
    Filed: March 15, 1995
    Date of Patent: November 19, 1996
    Assignee: Matsushita Electric Industrial Co., Ltd.
    Inventors: Takehiko Ide, Hiroki Kokubu, Takahisa Shiramizu, Yuji Tanaka, Tetsuo Hayama, Takashi Takeda, Hiroyuki Fukusako, Keisuke Shiba, Akihiro Nishiyama, Norio Amamoto, Hidehito Nakamura, Tsutomu Egashira, Kouji Okada